Company Overview

Update
Founded:
2003
Headquarters:
San Diego, CA
Funding:
$177.80M
Categories:
Biotechnology

Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.

Description

Update

Vital Therapies, Inc. is a biotherapeutic company focused on developing a cell-based therapy targeting the treatment of acute liver failure. Our product candidate, the ELAD® System, or ELAD, is a bio-artificial liver therapy that operates outside the body, or extracorporeal, and is designed with the proposed intent to allow the patient’s own liver to regenerate to a healthy state, or to stabilize the patient until liver transplant. ELAD is an allogeneic cellular therapy system incorporating our human liver-derived C3A cells contained in four hollow fiber cartridges that are combined with a single use customized disposable set and a reusable bedside unit. Data from ELAD clinical studies has shown trends that may indicate a potential to increase survival rates in patients with acute liver failure. ELAD has received orphan designation in the United States and Europe for the treatment of acute liver failure. Prior to the initiation of... See More

Current Team (9)

Update

Board Members and Advisors (5)

Update

Funding Rounds (7) - $177.80M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    15010 Avenue of Science

    Suite 200

    San Diego, CA 92128

    USA

Images (1)

Update
  • Cc209eec4a0638c8ce37e132cc3157fd